Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.77
Bid: 9.74
Ask: 10.20
Change: 0.00 (0.00%)
Spread: 0.46 (4.723%)
Open: 9.77
High: 0.00
Low: 0.00
Prev. Close: 9.77
BVA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AT1 Issuance for a total nominal amount

9 Nov 2017 07:00

RNS Number : 9890V
Banco Bilbao Vizcaya Argentaria SA
08 November 2017
 

 

 

 

 

Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA"), in compliance with the Securities Market legislation, and further to the relevant information dated 7th November 2017, hereby proceeds to notify the following:

 

 

RELEVANT INFORMATION

 

 

 

BBVA has agreed to carry out an issue of preferred securities contingently convertible into newly issued ordinary shares of BBVA with exclusion of pre-emptive subscription rights for shareholders (the "Securities") for a total nominal amount of 1,000,000,000 US Dollars (the "Issuance").

 

The remuneration of the Securities, whose payment is subject to certain conditions and to the discretion of the Bank, has been set at 6.125% on an annual basis for the first ten years. After that, it will be reviewed in accordance with the applicable terms and conditions of the Issuance by applying a margin of 387 basis points on the 5-year Mid-Swap Rate.

 

BBVA will request that the Securities qualify as Additional Tier 1 Capital pursuant to Law 10/2014, of 26 June, on regulation, supervision and solvency of credit entities and Regulation (EU) No. 575/2013 of the European Parliament and of the Council of 26 June 2013, on prudential requirements for credit institutions and investment firms.

 

The Securities shall not be offered, distributed or sold in Spain or to Spanish tax residents, without prejudice to the additional sales restrictions set out in the terms and conditions of the Issuance.

 

BBVA will request the listing of the Securities on the Global Exchange Market of the Irish Stock Exchange plc.

 

Furthermore, BBVA informs that, for the purposes set out in articles 414, 417 and 511 of the Corporate Enterprises Act, the director's report and the report of the independent expert/auditor of accounts different from BBVA's auditor, both related to the Issuance, have been issued. These reports will be available to shareholders through their publication on BBVA's website (www.bbva.com) on the Issuance closing date (expected to take place on 16th November 2017) and will be reported to the first General Shareholders' Meeting to be held after the Issuance.

 

 

 

Madrid, 8 November 2017

 

 

 

Important information:

There are restrictions with respect to the offering of the Securities in various jurisdictions, including the United Kingdom, Spain, Japan, Singapore, Hong Kong, Canada, Switzerland and the European Economic Area.

This document may not be distributed, directly or indirectly, in any jurisdiction in which said distribution is contrary to applicable laws.

This document is not a prospectus and is not an offer or a solicitation to buy, sell, subscribe or exchange any securities issued or to be issued by BBVA. No such offer in relation to the Securities shall be conducted in any jurisdiction in which said offer is not made in conformity with the applicable legislation.

This document is not an offer for sale of securities in the United States and the Securities may not be offered or sold in the United States nor to, on behalf or for the benefit of, any citizen of the United States, as defined in the Regulation S of the US Securities Act of 1933, as amended ("US Securities Act"), unless such Issuance is registered or falls under an exception of registration pursuant the US Securities Act.

In relation with the Issuance, BBVA has filed a registration statement (including a prospectus), and a prospectus supplement with the US Securities and Exchange Commission (the "SEC"). Before you invest, you should read the prospectus and prospectus supplement included in that registration statement and the other documents BBVA has filed with the SEC for more complete information about BBVA and the Issuance. You may obtain these documents for free by visiting the SEC web site at www.sec.gov.

This announcement is not a prospectus but rather is an announcement, and investors should not subscribe for any Securities except on the basis of the information contained in the prospectus, the prospectus supplement and the other documents filed by BBVA with the SEC that are incorporated by reference in the registration statement.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAFFPESXXFAF
Date   Source Headline
3rd Feb 20227:03 amRNS4Q21 Results Press Release
3rd Feb 20227:00 amRNS4Q21 Results Report
1st Feb 202210:21 amRNS220201_BBVA_SBB Follow up Reporting
25th Jan 202210:22 amRNS4Q21 Results Presentation Announcement
21st Jan 202211:58 amRNS220121_BBVA_SBB Follow up Reporting
14th Jan 202210:14 amRNS220114_BBVA_SBB Follow up Reporting
10th Jan 202211:21 amRNS220110_BBVA_SBB Follow up Reporting
6th Jan 202212:37 pmRNSPre-Stab Notice BBVA EUR 1bn due 14th Jan 2022
4th Jan 20227:00 amRNS220103_BBVA_Share Buyback Follow up Reporting
29th Dec 20219:34 amRNSBBVA_ Shares Buyback_Follow up Reporting
29th Dec 20217:00 amRNSBBVA Amendment to the Final Terms
29th Dec 20217:00 amRNSBBVA GBP Final Terms
17th Dec 202110:48 amRNS2021.12.17 Share Buyback Follow up Reporting
17th Dec 20217:00 amRNSS&P's Upgrades BBVA's ratings
10th Dec 202110:18 amRNSBBVA_ Shares Buyback_Follow up Reporting
1st Dec 202110:19 amRNSBBVA_ Shares Buyback_Follow up Reporting
26th Nov 202111:24 amRNSShares Buyback Follow up Reporting
19th Nov 20214:51 pmRNSBuyback Execution
18th Nov 202112:35 pmRNSBBVA_Investor_Day_Presentations
18th Nov 202112:28 pmRNSNew shareholder's distribution policy
18th Nov 20217:00 amRNSBBVA disclosure CMB application
16th Nov 20212:15 pmRNSInvestor Day Announcement
15th Nov 20217:20 amRNSAnalysts Call _ BBVA's Voluntary Takeover Bid
15th Nov 20217:03 amRNSVoluntary Takeover Bid for Türkiye Garanti Bankasi
29th Oct 20217:00 amRNS3Q21 Results Press Release
29th Oct 20217:00 amRNS3Q21 Results Presentation
29th Oct 20217:00 amRNSAuthorization Share Buyback
29th Oct 20217:00 amRNS3Q21 Results Report
19th Oct 202110:12 amRNS3Q21 Results Presentation Announcement
30th Sep 20217:47 amRNSDividend October 2021
30th Jul 20215:48 pmRNS2020 EU-wide Stress Test
30th Jul 20217:00 amRNS2Q21 Results Presentation
30th Jul 20217:00 amRNS2Q21 Results Press Release
30th Jul 20217:00 amRNS2Q21 Results Report
29th Jul 20216:18 pmRNSChanges in the Organizational Structure
21st Jul 202111:23 amRNS2Q21 Results Presentation Announcement
13th Jul 20215:21 pmRNSMoody's upgrades BBVA's Subordinated debt
1st Jul 20218:28 amRNSHR Selection of statutory auditor BBVA
9th Jun 20217:00 amRNSHR Agreement on the collective layoff
1st Jun 20212:47 pmRNSClosing BBVA USA sale
1st Jun 20217:00 amRNS2021 MREL Requirement
30th Apr 20217:18 amRNS1Q21 Results Presentation
30th Apr 20217:16 amRNS1Q21 Results Press Release
30th Apr 20217:14 amRNS1Q21 Results Report
23rd Apr 202110:29 amRNS1Q21 Results Presentation Announcement
20th Apr 20213:36 pmRNSPost-Stabilisation Notice - BBVA
20th Apr 20212:21 pmRNSResolutions SGM 2021
17th Mar 20217:00 amRNSPre-Stabilisation Notice - BBVA
16th Mar 20217:36 amRNS2021 AGM Proposed Resolutions
16th Mar 20217:00 amRNSCash payment against share premium acc. calendar

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.